Shabangu et al. [115] also concluded that cytochrome P450 2E1, toll-like receptor-9, homocysteine, and PPARγ in EV could be used as potential diagnostic biomarkers for NAFLD. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.